Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9154668 | 0.81 | TSHR (0.44) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL284018 | 0.71 | TSHR (0.40) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL6555695 | 0.70 | ALDH1A1 (0.39) | ALDH1A1L3MBTL1TSHRCYP2D6CYP2C19 | |
| Ammonia Solution, Strong SCHEMBL28651755 | 0.69 | TSHR (0.38) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL10830599 | 0.69 | TSHR (0.38) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL28727403 | 0.69 | TSHR (0.38) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL9710097 | 0.69 | TSHR (0.38) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL28011339 | 0.68 | ALDH1A1 (0.37) | ALDH1A1L3MBTL1TSHRCYP2D6CYP2C19 | |
| SCHEMBL800011 | 0.67 | ALDH1A1 (0.36) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL5274369 | 0.67 | TSHR (0.36) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1210854-A | Synthesis of carboxylalkyl thiosuccnic acid | ELF AQUITAINE EXPLORATION PROD (FR) | 1999-03-17 | — | — | CN | disclosed |